Chad Wyrowski • TD Cowen

Chad Wyrowski is a Managing Director and Senior Equity Research Analyst at TD Cowen, specializing in the U.S. Healthcare sector with a particular focus on Diagnostics, Tools, and Medical Devices. He actively covers companies such as Abbott Laboratories, QuidelOrtho, Hologic, Danaher, and Thermo Fisher Scientific, and is recognized for his deep insights and data-driven research, maintaining a strong track record of accurate stock recommendations with a success rate above 60% and average annualized returns outperforming sector benchmarks. Wyrowski began his Wall Street career in 2006, with prior experience at Morgan Stanley and Bank of America Merrill Lynch, before joining TD Cowen in 2018. He holds FINRA Series 7, 63, 86, and 87 registrations, and has received industry accolades for his thought leadership and research quality.